Lv11
78 积分 2023-12-12 加入
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
1小时前
已完结
Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
10天前
已完结
Myasthenia gravis: subgroup classification and therapeutic strategies
15天前
已完结
Bispecific BCMA/CD19 targeted CAR-T cell therapy forces sustained disappearance of symptoms and anti-acetylcholine receptor antibodies in refractory myasthenia gravis: a case report
16天前
已完结
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis
26天前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
1个月前
已完结
CAR T-cell therapy in autoimmune diseases
1个月前
已完结
Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study
1个月前
已完结
T follicular helper cells in autoimmune diseases
1个月前
已完结
Recent progress in chimeric antigen receptor therapy for acute myeloid leukemia
2个月前
已完结
皖公网安备34019202002308
